AD patients had elevated MPO levels (132.8 ± 114.8 ng/mL) and Aβ1-40 (40 ± 8 pg/mL) levels compared to healthy patients (55 ± 42.6 ng/mL and 36 ± 7 pg/mL). This evidence concerns the gene MPO and Alzheimer disease.